Granules India Limited (BOM:532482)
India · Delayed Price · Currency is INR 748.90
-0.15 (-0.02%)
At close: Jun 16, 2026
Granules India Market Cap
Granules India has a market cap or net worth of 185.58 billion as of June 16, 2026. Its market cap has increased by 44.75% in one year.
Market Cap
185.58B
Enterprise Value
191.20B
Revenue
53.66B
Ranking
n/a
PE Ratio
30.62
Stock Price
748.90
Market Cap Chart
Since February 7, 2003, Granules India's market cap has increased from 163.70M to 185.58B, an increase of 113,262.87%. That is a compound annual growth rate of 35.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 185.58B | 27.76% |
| Dec 31, 2025 | 145.25B | 1.29% |
| Dec 31, 2024 | 143.40B | 45.94% |
| Dec 29, 2023 | 98.26B | 27.40% |
| Dec 30, 2022 | 77.13B | -7.49% |
| Dec 31, 2021 | 83.37B | -4.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abbott India | 558.26B |
| J. B. Chemicals & Pharmaceuticals | 363.09B |
| GlaxoSmithKline Pharmaceuticals | 359.26B |
| Rubicon Research | 213.43B |
| AstraZeneca Pharma India | 206.10B |
| Caplin Point Laboratories | 183.29B |
| Jubilant Pharmova | 154.48B |
| Viyash Scientific | 109.09B |